Tenax Therapeutics, Inc. (TENX)
TENX Stock Price Chart
Explore Tenax Therapeutics, Inc. interactive price chart. Choose custom timeframes to analyze TENX price movements and trends.
TENX Company Profile
Discover essential business fundamentals and corporate details for Tenax Therapeutics, Inc. (TENX) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
4 Apr 1994
Employees
4.00
Website
https://www.tenaxthera.comCEO
Christopher T. Giordano
Description
Tenax Therapeutics, Inc. is a specialized pharmaceutical enterprise dedicated to discovering, advancing, and bringing to market therapies for cardiovascular and pulmonary conditions throughout the United States and Canada. Its product pipeline features TNX-103 and TNX-102 (levosimendan), both of which have successfully completed Phase II clinical trials. These compounds are being developed to manage pulmonary hypertension, particularly that linked to heart failure with preserved ejection fraction (HFpEF), as well as other forms of associated pulmonary hypertension. Additionally, the company is progressing TNX-201 (imatinib), a tyrosine kinase inhibitor, designed to treat pulmonary arterial hypertension. Founded in 1967, the organization was initially known as Oxygen Biotherapeutics, Inc. until its rebranding to Tenax Therapeutics, Inc. in September 2014. The company maintains its corporate headquarters in Morrisville, North Carolina.
TENX Financial Timeline
Browse a chronological timeline of Tenax Therapeutics, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 12 Aug 2026
EPS estimate is -$0.40.
Earnings released on 12 May 2026
EPS came in at -$0.35 surpassing the estimated -$0.40 by +12.50%.
Earnings released on 10 Mar 2026
EPS came in at -$0.38 surpassing the estimated -$1.26 by +69.84%.
Earnings released on 12 Nov 2025
EPS came in at -$0.40 surpassing the estimated -$1.33 by +69.92%.
Earnings released on 13 Aug 2025
EPS came in at -$0.27 surpassing the estimated -$0.50 by +46.00%.
Earnings released on 14 May 2025
EPS came in at -$0.28 surpassing the estimated -$0.48 by +41.67%.
Earnings released on 25 Mar 2025
EPS came in at -$0.18 surpassing the estimated -$0.52 by +65.38%.
Earnings released on 13 Nov 2024
EPS came in at -$0.19 surpassing the estimated -$1.38 by +86.23%.
Earnings released on 13 Aug 2024
EPS came in at -$1.83 surpassing the estimated -$1.99 by +8.04%.
Earnings released on 14 May 2024
EPS came in at -$3.12 falling short of the estimated -$2.40 by -30.00%.
Earnings released on 28 Mar 2024
EPS came in at -$12.98 falling short of the estimated -$8.14 by -59.46%, while revenue for the quarter reached $5.79k .
Stock split effective on 3 Jan 2024
Shares were split 1 : 80 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 13 Nov 2023
EPS came in at -$6.40 surpassing the estimated -$7.20 by +11.11%.
Earnings released on 14 Aug 2023
EPS came in at -$4.00 falling short of the estimated -$0.10 by -3.90k%.
Earnings released on 15 May 2023
EPS came in at -$12.00 falling short of the estimated -$0.37 by -3.14k%.
Earnings released on 30 Mar 2023
EPS came in at -$1.73 surpassing the estimated -$2.28 by +24.12%.
Stock split effective on 5 Jan 2023
Shares were split 1 : 20 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 10 Nov 2022
EPS came in at -$176.00 matching the estimated -$176.00.
Earnings released on 11 Aug 2022
EPS came in at -$176.00 falling short of the estimated -$144.00 by -22.22%.
Earnings released on 16 May 2022
EPS came in at -$176.00 falling short of the estimated -$144.00 by -22.22%.
Earnings released on 31 Mar 2022
EPS came in at -$0.80 surpassing the estimated -$3.20 by +75.00%.
Earnings released on 16 Nov 2021
EPS came in at -$240.00 falling short of the estimated -$208.00 by -15.38%.
Earnings released on 16 Aug 2021
EPS came in at -$160.00 falling short of the estimated -$0.13 by -122.98k%.
TENX Stock Performance
Access detailed TENX performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
